Jay A. Moore

536 citations
14 papers · 166 · 1 hit paper · h-index 7

Impact in

    • Lung Cancer Research Studies
    • PARP inhibition in cancer therapy
    • Pancreatic and Hepatic Oncology Research
    • Cancer Genomics and Diagnostics

Papers in

Jay A. Moore

12 papers receiving 165 citations

Jay A. Moore's Hit Papers

Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation 2023 · 75 citations
750+1+2Years since publication255075

Peers

Jay A. Moore
Comparison fields: 5 of 31
  • Oncology 116
  • Cancer Research 36
  • Pulmonary and Respiratory Medicine 51
  • Epidemiology 49
  • Molecular Biology 75
Replace Masayuki Shirasawa with:
Masayuki Shirasawa Japan
Yang Ma China
Justin Harold United States
Abirami Sivapiragasam United States
Christiane Kuempers Germany
Diana Agostini‐Vulaj United States
J. G. M. Segalla Brazil
Erik Asmus United States
David Dum Germany
Jay A. Moore relative to Masayuki Shirasawa Japan Masayuki Shirasawa's profile →
Citations per field
00.5×2.8×
Masayuki Shirasawa · 1×
Citations per year

Countries citing papers authored by Jay A. Moore

Since Specialization
Citations

This map shows the geographic impact of Jay A. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay A. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay A. Moore more than expected).

Fields of papers citing papers by Jay A. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay A. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay A. Moore. The network helps show where Jay A. Moore may publish in the future.

Co-authors

The 25 scholars most cited alongside Jay A. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay A. Moore Line = papers co-authored together Jay A. Moore links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation
Hit paper breakdown →
202375
2 199320
3 202214
4 202313
5 202112
6 202311
7 20217
8 20235
9 20243
10 20213
11 20212
12 20181
13 20240
14 20240

About Jay A. Moore

Jay A. Moore is a scholar working on Cancer Research, Oncology, Surgery, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 14 papers that have together received 166 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Prostate Cancer Treatment and Research (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Renal and related cancers (1 paper). The work is most often cited by research in Oncology (116 citations), Cancer Research (36 citations), Pulmonary and Respiratory Medicine (51 citations), Epidemiology (49 citations) and Molecular Biology (75 citations). Jay A. Moore has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Garrett M. Frampton, Justin Y. Newberg, Radwa Sharaf, Smruthy Sivakumar, Meagan Montesion, Ericka M. Ebot, Christine M. Lovly, Quintin Pan, Caterina I. Colón and Douglas I. Lin. Their work appears in journals such as JCO Precision Oncology, Journal of Clinical Oncology, Blood, JNCI Journal of the National Cancer Institute and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact